Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment

This study has been completed.

Sponsored by:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00087932

Purpose

The purpose of this study is to determine whether differences in the use of complementary and alternative medicine (CAM) are influenced by the socioeconomic status and ethnicity of cancer patients.

Condition
Neoplasms

MedlinePlus related topics: Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	Socioeconomic Diversity of CAM Integration in Oncology

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	300
Study Start Date:	September 2001
Estimated Study Completion Date:	August 2003

Detailed Description:

The use of CAM is common among patients with cancer. However, there may be differences in participation, treatment preferences, and quality of life that are influenced by socioeconomic factors and ethnicity. This study will compare two distinct socioeconomic groups to determine differences in CAM use.

Participants in this study will complete a questionnaire regarding demographics, socioeconomic status, disease specifics, and facilitators and barriers to CAM use. Participation in an introductory seminar and in various CAM programs will be monitored. Participants will also complete a quality of life scale that will provide insight into the way different populations perceive and use CAM and will identify potential obstacles to integrating CAM into other cancer treatment programs.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Cancer diagnosis
Able to read and understand English

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00087932

Locations

United States, Michigan
Assarian Cancer Center
Novi, Michigan, United States, 48374

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators

Principal Investigator:

June L. Chan, MD

University of Michigan

More Information

Study ID Numbers:	R21 AT000880
Study First Received:	July 15, 2004
Last Updated:	August 17, 2006
ClinicalTrials.gov Identifier:	NCT00087932
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Complementary Therapies

Additional relevant MeSH terms:

Neoplasms

ClinicalTrials.gov processed this record on January 15, 2009